Cellular calcium and cardiac cell death.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002118:Calcium / Q000037:antagonists & inhibitors / Q000378:metabolism*; D002463:Cell Membrane Permeability; D002470:Cell Survival; D003327:Coronary Disease / Q000378:metabolism* / Q000517:prevention & control; D006324:Heart Arrest, Induced / Q000009:adverse effects*; D006801:Humans; D009206:Myocardium / Q000166:cytology / Q000378:metabolism*; D009543:Nifedipine / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D012508:Sarcolemma / Q000378:metabolism; D014700:Verapamil / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D011725:Pyridines; D000255:Adenosine Triphosphate; D014700:Verapamil; D009543:Nifedipine; D002118:Calcium